🏅 FDA Orphan Designation
Ammonul
benzoate/phenylacetate
Manufacturer: Medicis Pharmaceutical Corp.
Indications & Usage
Adjunctive therapy in the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle.
💙 Support Programs
View all →Ammonul
Medicis Pharmaceutical Corp.
Ammonul
Medicis Pharmaceutical Corp.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.